Does ruxolitinib really prolong survival in individuals with myelofibrosis? The never-ending story

Detalles Bibliográficos
Autores principales: Barosi, Giovanni, Gale, Robert Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006303/
https://www.ncbi.nlm.nih.gov/pubmed/35240682
http://dx.doi.org/10.1182/bloodadvances.2022007230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006303/
https://www.ncbi.nlm.nih.gov/pubmed/35240682
http://dx.doi.org/10.1182/bloodadvances.2022007230

Ejemplares similares